Triptorelin Prescribing at ROTHSCHILD HOUSE GROUP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
233
Total Quantity
234
NHS Cost
£43.3K
vs National Avg
+1004.7%
ROTHSCHILD HOUSE GROUP prescribed 233 items of Triptorelin over the last 12 months at a cost of £43,332 to the NHS. This is 1004.7% above the national average prescribing rate. Triptorelin is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
27
Jun 2026
16
Jun 2026
6
Jun 2026
31
Jun 2026
20
Jun 2026
12
Jun 2026
23
Jun 2026
16
Jun 2026
18
Jun 2026
27
Jun 2026
15
Jun 2026
22
Prescribing Details
| Total Items | 233 |
|---|---|
| Total Quantity | 234 |
| Total NHS Cost | £43,332 |
| Presentations | 2 different forms |
| vs National Average | +1004.7% |
Triptorelin Prescribing Comparison
| This practice | 233 items |
|---|---|
| National average per practice | 21 items |
| Difference | +1004.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.